US4309430A
(en)
|
1980-06-27 |
1982-01-05 |
Merck & Co., Inc. |
Pyrazinyl-1,2,4-oxadiazole-5-ones, for treatment of edema, and processes for preparing same
|
US5329012A
(en)
|
1987-10-29 |
1994-07-12 |
The Research Foundation Of State University Of New York |
Bis(acyloxmethyl)imidazole compounds
|
JP2597917B2
(en)
|
1990-04-26 |
1997-04-09 |
富士写真フイルム株式会社 |
Novel dye-forming coupler and silver halide color photographic material using the same
|
BR9608100A
(en)
|
1995-05-09 |
1999-02-23 |
Basf Ag |
Pyrazolo [1,5a] pyrimidine processes for their preparation and for the control and harmful fungi and pests composition and use of compounds
|
WO1997043267A1
(en)
|
1996-05-11 |
1997-11-20 |
Kings College London |
Pyrazines
|
ES2294800T3
(en)
|
1996-07-24 |
2008-04-01 |
Bristol-Myers Squibb Pharma Company |
AZOLO TRIAZINAS AND PYRIMIDINS.
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
US6060478A
(en)
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
JPH10218881A
(en)
|
1997-02-03 |
1998-08-18 |
Pola Chem Ind Inc |
New pyrrolopyrazolopyrimidine derivative
|
JP2002241379A
(en)
|
1997-03-21 |
2002-08-28 |
Dainippon Pharmaceut Co Ltd |
3-oxadiazolylquinoxaline derivative
|
JP2002501532A
(en)
|
1997-05-30 |
2002-01-15 |
メルク エンド カンパニー インコーポレーテッド |
Novel angiogenesis inhibitors
|
US6235741B1
(en)
|
1997-05-30 |
2001-05-22 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
CN1146561C
(en)
|
1998-07-16 |
2004-04-21 |
盐野义制药株式会社 |
Pyrimidine derivatives exhibiting antitumor activity
|
US6245759B1
(en)
|
1999-03-11 |
2001-06-12 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
JP2001302666A
(en)
|
1999-09-21 |
2001-10-31 |
Nissan Chem Ind Ltd |
Azole-condensed heterocyclic anilide compound and herbicide
|
MY125533A
(en)
|
1999-12-06 |
2006-08-30 |
Bristol Myers Squibb Co |
Heterocyclic dihydropyrimidine compounds
|
ES2296667T3
(en)
|
1999-12-17 |
2008-05-01 |
Novartis Vaccines And Diagnostics, Inc. |
INHIBITORS BASED ON PIRAZINA DE GLICOGENO SINTASA QUINASA-3.
|
AU2001264932A1
(en)
|
2000-05-26 |
2001-12-11 |
Neurogen Corporation |
Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands
|
US20020041880A1
(en)
|
2000-07-05 |
2002-04-11 |
Defeo-Jones Deborah |
Method of treating cancer
|
US6849660B1
(en)
|
2000-08-01 |
2005-02-01 |
Isis Pharmaceuticals, Inc. |
Antimicrobial biaryl compounds
|
US7067520B2
(en)
|
2000-11-17 |
2006-06-27 |
Ishihara Sangyo Kaisha, Ltd. |
Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
EP1408986B1
(en)
|
2001-05-08 |
2008-09-24 |
Yale University |
Proteomimetic compounds and methods
|
US20030114467A1
(en)
|
2001-06-21 |
2003-06-19 |
Shakespeare William C. |
Novel pyrazolo- and pyrrolo-pyrimidines and uses thereof
|
SE0102439D0
(en)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
SE0102438D0
(en)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
US6833371B2
(en)
|
2001-11-01 |
2004-12-21 |
Icagen, Inc. |
Pyrazolopyrimidines
|
ES2333586T3
(en)
|
2001-11-21 |
2010-02-24 |
PHARMACIA & UPJOHN COMPANY LLC |
DERIVATIVES OF ARIL 1,4-PIRAZINA SUBSTITUTED.
|
US6992087B2
(en)
|
2001-11-21 |
2006-01-31 |
Pfizer Inc |
Substituted aryl 1,4-pyrazine derivatives
|
KR20040084896A
(en)
|
2002-02-06 |
2004-10-06 |
버텍스 파마슈티칼스 인코포레이티드 |
Heteroaryl compounds useful as inhibitors of gsk-3
|
EP1485365B1
(en)
|
2002-03-13 |
2008-05-14 |
Janssen Pharmaceutica N.V. |
Sulfonyl-derivatives as novel inhibitors of histone deacetylase
|
GB0206860D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
TWI319387B
(en)
|
2002-04-05 |
2010-01-11 |
Astrazeneca Ab |
Benzamide derivatives
|
GB0209715D0
(en)
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
US7704995B2
(en)
|
2002-05-03 |
2010-04-27 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
CA2484209C
(en)
|
2002-05-03 |
2013-06-11 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
AU2003241925A1
(en)
|
2002-05-31 |
2003-12-19 |
Eisai R&D Management Co., Ltd. |
Pyrazole compound and medicinal composition containing the same
|
ES2304511T3
(en)
|
2002-06-04 |
2008-10-16 |
Schering Corporation |
PIRAZOLO COMPOUNDS (1,5-A) PYRIMIDINE AS ANTIVIRAL AGENTS.
|
US7449488B2
(en)
|
2002-06-04 |
2008-11-11 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
US7015227B2
(en)
|
2002-06-21 |
2006-03-21 |
Cgi Pharmaceuticals, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
KR20050033659A
(en)
|
2002-09-04 |
2005-04-12 |
쉐링 코포레이션 |
Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors
|
MXPA05002571A
(en)
|
2002-09-04 |
2005-09-08 |
Schering Corp |
Pyrazolopyrimidines as cyclin-dependent kinase inhibitors.
|
US7196078B2
(en)
|
2002-09-04 |
2007-03-27 |
Schering Corpoartion |
Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
US8580782B2
(en)
|
2002-09-04 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
KR20050057139A
(en)
|
2002-09-04 |
2005-06-16 |
쉐링 코포레이션 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
MXPA05002573A
(en)
|
2002-09-04 |
2005-09-08 |
Schering Corp |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors.
|
US7563798B2
(en)
|
2002-09-04 |
2009-07-21 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
US7601724B2
(en)
|
2002-09-04 |
2009-10-13 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
US7205308B2
(en)
|
2002-09-04 |
2007-04-17 |
Schering Corporation |
Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
|
US7196092B2
(en)
|
2002-09-04 |
2007-03-27 |
Schering Corporation |
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
US8673924B2
(en)
|
2002-09-04 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
AU2003282679A1
(en)
|
2002-10-04 |
2004-05-04 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles for use against metabolic-related disorders
|
WO2004052315A2
(en)
|
2002-12-11 |
2004-06-24 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
SE0203754D0
(en)
|
2002-12-17 |
2002-12-17 |
Astrazeneca Ab |
New compounds
|
SE0203752D0
(en)
|
2002-12-17 |
2002-12-17 |
Astrazeneca Ab |
New compounds
|
GEP20084341B
(en)
|
2003-02-26 |
2008-03-25 |
Sugen Inc |
Aminoheteroaryl compounds as protein kinase inhibitors
|
EP1599482A4
(en)
|
2003-02-28 |
2008-10-01 |
Teijin Pharma Ltd |
Pyrazolo 1,5-a pyrimidine derivatives
|
EP1606267B1
(en)
|
2003-03-11 |
2008-07-30 |
Pfizer Products Inc. |
Pyrazine compounds as transforming growth factor (tgf) inhibitors
|
JP2006520794A
(en)
|
2003-03-21 |
2006-09-14 |
スミスクライン ビーチャム コーポレーション |
Compound
|
EP1608622A4
(en)
|
2003-03-24 |
2009-04-01 |
Merck & Co Inc |
Biaryl substituted 6-membered heterocyles as sodium channel blockers
|
GB2400101A
(en)
|
2003-03-28 |
2004-10-06 |
Biofocus Discovery Ltd |
Compounds capable of binding to the active site of protein kinases
|
US20060252741A1
(en)
|
2003-05-15 |
2006-11-09 |
Colandrea Vincent J |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
AR045595A1
(en)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
USEFUL COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS
|
BRPI0414533A
(en)
|
2003-09-18 |
2006-11-07 |
Conforma Therapeutics Corp |
compound, pharmaceutical composition, and methods for inhibiting an hsp90 and treating an individual having an hsp90 mediated disorder
|
US7807696B2
(en)
|
2003-10-07 |
2010-10-05 |
The Feinstein Institute For Medical Research |
Isoxazole and isothiazole compounds useful in the treatment of inflammation
|
AU2004293019B2
(en)
|
2003-11-19 |
2010-10-28 |
Array Biopharma Inc. |
Bicyclic inhibitors of MEK and methods of use thereof
|
DE10356579A1
(en)
|
2003-12-04 |
2005-07-07 |
Merck Patent Gmbh |
amine derivatives
|
JP2007524682A
(en)
|
2004-02-12 |
2007-08-30 |
メルク エンド カムパニー インコーポレーテッド |
Bipyridylamide as a regulator of metabotropic glutamate receptor-5
|
JP2007523939A
(en)
|
2004-02-25 |
2007-08-23 |
ビーエーエスエフ アクチェンゲゼルシャフト |
Azolopyrimidine compounds and their use to combat parasitic fungi
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
WO2005123672A2
(en)
|
2004-06-14 |
2005-12-29 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
CA2573573A1
(en)
|
2004-07-27 |
2006-02-09 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
US7626021B2
(en)
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
US7528138B2
(en)
|
2004-11-04 |
2009-05-05 |
Vertex Pharmaceuticals Incorporated |
Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
|
US8003806B2
(en)
|
2004-11-12 |
2011-08-23 |
OSI Pharmaceuticals, LLC |
Integrin antagonists useful as anticancer agents
|
WO2006058074A1
(en)
|
2004-11-22 |
2006-06-01 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
GB0428235D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Novel compounds
|
US20080269249A2
(en)
|
2004-12-27 |
2008-10-30 |
Alcon, Inc. |
Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
US20060156482A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
CN101163692B
(en)
|
2005-02-16 |
2012-01-18 |
先灵公司 |
Heterocyclic substituted piperazines with cxcr3 antagonist activity
|
DE102005007534A1
(en)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
pyrazolopyrimidine
|
ATE524467T1
(en)
|
2005-04-25 |
2011-09-15 |
Merck Patent Gmbh |
NOVEL AZA HETEROCYCLES AS KINASE INHIBITORS
|
US20070155738A1
(en)
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
BRPI0609802A2
(en)
|
2005-05-20 |
2017-05-02 |
Alantos Pharmaceuticals Holding Inc |
compound, pharmaceutical composition and use of a compound
|
US20070155737A1
(en)
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
WO2007015632A1
(en)
|
2005-08-04 |
2007-02-08 |
Cgk Co., Ltd. |
Atm and atr inhibitor
|
ATE533770T1
(en)
|
2005-10-06 |
2011-12-15 |
Schering Corp |
PYRAZOLOPYRIMIDINES AS PROTEIN KINASE INHIBITORS
|
WO2007044407A2
(en)
|
2005-10-06 |
2007-04-19 |
Schering Corporation |
Pyrazolo (1 , 5a) pyrimidines as protein kinase inhibitors
|
EP1940847A2
(en)
|
2005-10-06 |
2008-07-09 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
EP1942900B1
(en)
|
2005-10-06 |
2015-06-03 |
Merck Sharp & Dohme Corp. |
Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting kinases methods for inhibiting protein kinases
|
US8372851B2
(en)
|
2005-10-21 |
2013-02-12 |
Exelixis, Inc. |
Pyrazolo pyrimidines as casein kinase II (CK2) modulators
|
AR056876A1
(en)
|
2005-10-21 |
2007-10-31 |
Tanabe Seiyaku Co |
PIRAZOLO COMPOUNDS [1-5-A] PYRIMIDINE, CB1 CANABINOID RECEPTORS ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS CONTAINING AND USES IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES, SUCH AS PSYCHOTIC AND NEIGHBORHOODS
|
TW200736260A
(en)
|
2005-11-10 |
2007-10-01 |
Smithkline Beecham Corp |
Inhibitors of Akt activity
|
DE602006011363D1
(en)
|
2005-12-01 |
2010-02-04 |
Hoffmann La Roche |
Heteroaryl-substituted steroid derivatives as L-CPT1 inhibitors
|
WO2007066805A1
(en)
|
2005-12-09 |
2007-06-14 |
Meiji Seika Kaisha, Ltd. |
Lincomycin derivative and antibacterial agent containing the same as active ingredient
|
US7655662B2
(en)
|
2005-12-22 |
2010-02-02 |
Alcon Research, Ltd. |
(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure
|
ITMI20060311A1
(en)
|
2006-02-21 |
2007-08-22 |
Btsr Int Spa |
PERFECT DEVICE FOR WIRE OR FILATIO SUPPLY TO A TEXTILE MACHINE AND METHOD TO IMPLEMENT THIS POWER SUPPLY
|
GB0603684D0
(en)
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
WO2007096764A2
(en)
|
2006-02-27 |
2007-08-30 |
Glenmark Pharmaceuticals S.A. |
Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
|
TW200800203A
(en)
|
2006-03-08 |
2008-01-01 |
Astrazeneca Ab |
New use
|
CN101479255B
(en)
|
2006-03-22 |
2013-05-01 |
沃泰克斯药物股份有限公司 |
C-MET protein kinase inhibitors for the treatment of proliferative disorders
|
BRPI0709699A2
(en)
|
2006-03-29 |
2011-07-26 |
Foldrx Pharmaceuticals Inc |
inhibition of alpha synuclein toxicity
|
EP2001870A2
(en)
|
2006-03-31 |
2008-12-17 |
Schering Corporation |
Kinase inhibitors
|
KR20090019796A
(en)
|
2006-05-22 |
2009-02-25 |
쉐링 코포레이션 |
Pyrazolo[1,5-a]pyrimidines as cdk inhibitors
|
US9216963B2
(en)
|
2006-06-22 |
2015-12-22 |
Medibeacon Inc. |
Pyrazine derivatives with extended conjugation and methods of using the same in optical applications
|
ATE456565T1
(en)
|
2006-06-22 |
2010-02-15 |
Biovitrum Ab Publ |
PYRIDINE AND PYRAZINE DERIVATIVES AS MNK KINASE INHIBITORS
|
AR061793A1
(en)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
PIRAZOLO COMPOUND [1,5-A] PYRIMIDINE AND PHARMACEUTICAL COMPOSITION
|
PE20121506A1
(en)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
TRIAZOLOPYRIDINE COMPOUNDS AS C-MET INHIBITORS
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
WO2008037477A1
(en)
|
2006-09-29 |
2008-04-03 |
Novartis Ag |
Pyrazolopyrimidines as p13k lipid kinase inhibitors
|
GB0619342D0
(en)
|
2006-09-30 |
2006-11-08 |
Vernalis R&D Ltd |
New chemical compounds
|
BRPI0717845A2
(en)
|
2006-10-04 |
2015-06-16 |
Hoffmann La Roche |
Use of compounds, pharmaceutical compositions and methods for the treatment and / or prophylaxis of diseases that can be treated with HDL-cholesterol elevating agents and compounds.
|
NZ576278A
(en)
|
2006-10-19 |
2011-12-22 |
Signal Pharm Llc |
Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors
|
CN101600714B
(en)
|
2006-11-10 |
2013-08-21 |
百时美施贵宝公司 |
Novel pyrindole kinase inhibitors
|
AU2007321924A1
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic metalloprotease inhibitors
|
CL2007003627A1
(en)
|
2006-12-15 |
2008-07-25 |
Bayer Schering Pharma Ag |
COMPOUNDS DERIVED FROM 3-H-PIRAZOLOPIRIDINAS; PREPARATION METHOD; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF DECREGULATED VASCULAR GROWTH DISEASES SUCH AS ACUTE MYELOGEN LEUKEMIA, RETINOPATIA, REUMATOID ARTHRITIS, PSORIAS
|
AU2007338792B2
(en)
|
2006-12-20 |
2012-05-31 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
GB0625659D0
(en)
|
2006-12-21 |
2007-01-31 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
PE20081581A1
(en)
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
PIRROLO [2,3-b] PYRIDINES COMPOUNDS AS KINASE MODULATORS
|
WO2008103277A2
(en)
|
2007-02-16 |
2008-08-28 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
|
BRPI0808523A2
(en)
|
2007-03-01 |
2014-08-19 |
Novartis Vaccines & Diagnostic |
PIM KINASE INHIBITORS AND METHODS OF USE
|
NZ580241A
(en)
|
2007-04-10 |
2011-02-25 |
Bayer Cropscience Ag |
Insecticidal aryl isoxazoline derivatives
|
PE20090288A1
(en)
|
2007-05-10 |
2009-04-03 |
Smithkline Beecham Corp |
QUINOXALINE DERIVATIVES AS PI3 KINASE INHIBITORS
|
PE20090717A1
(en)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS
|
EP2014661A1
(en)
|
2007-06-13 |
2009-01-14 |
Bayer CropScience AG |
Hererocyclically substituted heterocyclic carboxylic acid derivates
|
UY31137A1
(en)
|
2007-06-14 |
2009-01-05 |
Smithkline Beecham Corp |
DERIVATIVES OF QUINAZOLINE AS INHIBITORS OF THE PI3 QUINASA
|
WO2008156174A1
(en)
|
2007-06-21 |
2008-12-24 |
Taisho Pharmaceutical Co., Ltd. |
Pyrazinamide compound
|
CA2691003A1
(en)
|
2007-06-26 |
2008-12-31 |
Lexicon Pharmaceuticals, Inc. |
Methods of treating serotonin-mediated diseases and disorders
|
US20090012103A1
(en)
|
2007-07-05 |
2009-01-08 |
Matthew Abelman |
Substituted heterocyclic compounds
|
WO2009006580A1
(en)
|
2007-07-05 |
2009-01-08 |
Cv Therapeutics, Inc. |
Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers
|
GB0713259D0
(en)
|
2007-07-09 |
2007-08-15 |
Astrazeneca Ab |
Pyrazine derivatives 954
|
JP5241834B2
(en)
|
2007-07-19 |
2013-07-17 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Heterocyclic amide compounds as protein kinase inhibitors
|
MY154668A
(en)
|
2007-07-19 |
2015-07-15 |
Lundbeck & Co As H |
5-membered heterocyclic amides and related compounds
|
AP2010005167A0
(en)
|
2007-08-01 |
2010-02-28 |
Pfizer |
Pyrazole compounds and their use as RAF inhibitors
|
WO2009017954A1
(en)
|
2007-08-01 |
2009-02-05 |
Phenomix Corporation |
Inhibitors of jak2 kinase
|
WO2009024825A1
(en)
|
2007-08-21 |
2009-02-26 |
Astrazeneca Ab |
2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors
|
EP2203436A1
(en)
|
2007-09-17 |
2010-07-07 |
Neurosearch A/S |
Pyrazine derivatives and their use as potassium channel modulators
|
KR20100089090A
(en)
|
2007-10-25 |
2010-08-11 |
아스트라제네카 아베 |
Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
|
EP2225247A1
(en)
|
2007-11-28 |
2010-09-08 |
Schering Corporation |
2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
WO2009075790A1
(en)
|
2007-12-07 |
2009-06-18 |
Alantos Pharmaceuticals Holding, Inc. |
Metalloprotease inhibitors for intra-articular application
|
US8703777B2
(en)
|
2008-01-04 |
2014-04-22 |
Intellikine Llc |
Certain chemical entities, compositions and methods
|
EP2085398A1
(en)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, a process for their preparation and their use as medicine
|
KR101261514B1
(en)
|
2008-02-25 |
2013-05-07 |
에프. 호프만-라 로슈 아게 |
Pyrrolopyrazine kinase inhibitors
|
WO2009106445A1
(en)
|
2008-02-25 |
2009-09-03 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazine kinase inhibitors
|
CN101952296B
(en)
|
2008-02-25 |
2013-08-21 |
霍夫曼-拉罗奇有限公司 |
Pyrrolopyrazine kinase inhibitors
|
ATE522536T1
(en)
|
2008-02-25 |
2011-09-15 |
Hoffmann La Roche |
PYRROLOPYRAZINE KINASE INHIBITORS
|
TW200940537A
(en)
|
2008-02-26 |
2009-10-01 |
Astrazeneca Ab |
Heterocyclic urea derivatives and methods of use thereof
|
JP2011515401A
(en)
|
2008-03-20 |
2011-05-19 |
アムジエン・インコーポレーテツド |
Aurora kinase modulator and methods of use
|
WO2009152087A1
(en)
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
Bicyclic heteroaryl compounds and methods for kinase modulation, and indications therefor
|
WO2010006086A2
(en)
|
2008-07-08 |
2010-01-14 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
GB0814364D0
(en)
|
2008-08-05 |
2008-09-10 |
Eisai London Res Lab Ltd |
Diazaindole derivatives and their use in the inhibition of c-Jun N-terminal kinase
|
JP2011530511A
(en)
|
2008-08-05 |
2011-12-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Therapeutic compounds
|
US8853125B2
(en)
|
2008-09-24 |
2014-10-07 |
Basf Se |
Pyrazole compounds for controlling invertebrate pests
|
AU2009307770A1
(en)
|
2008-10-21 |
2010-04-29 |
Vertex Pharmaceuticals Incorporated |
C-Met protein kinase inhibitors
|
AU2009308675A1
(en)
|
2008-10-31 |
2010-05-06 |
Genentech, Inc. |
Pyrazolopyrimidine JAK inhibitor compounds and methods
|
JP5702293B2
(en)
|
2008-11-10 |
2015-04-15 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
AU2009324894B2
(en)
|
2008-11-25 |
2015-04-09 |
University Of Rochester |
MLK inhibitors and methods of use
|
SG171956A1
(en)
|
2008-12-05 |
2011-07-28 |
Hoffmann La Roche |
Pyrrolopyrazinyl urea kinase inhibitors
|
SI3354650T1
(en)
|
2008-12-19 |
2022-06-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
RU2505540C2
(en)
|
2008-12-23 |
2014-01-27 |
Эббви Инк. |
Antiviral compounds
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
US8492582B2
(en)
|
2009-01-30 |
2013-07-23 |
Toyama Chemical Co., Ltd. |
N-acyl anthranilic acid derivative or salt thereof
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
SG173639A1
(en)
|
2009-02-11 |
2011-09-29 |
Sunovion Pharmaceuticals Inc |
Histamine h3 inverse agonists and antagonists and methods of use thereof
|
CN101537007A
(en)
|
2009-03-18 |
2009-09-23 |
中国医学科学院血液病医院(血液学研究所) |
Application of N-(thiofuran-2) pyrazolo (1, 5-a) pyridine-3-formanides compounds for preparing antineoplastic
|
WO2010111653A2
(en)
|
2009-03-27 |
2010-09-30 |
The Uab Research Foundation |
Modulating ires-mediated translation
|
UA110324C2
(en)
*
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
AR077468A1
(en)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
PIRAZOLO COMPOUNDS (1,5-A) PYRIMIDINE SUBSTITUTED AS TRK-QUINASA INHIBITORS
|
CN102471345A
(en)
|
2009-07-15 |
2012-05-23 |
雅培制药有限公司 |
Pyrrolopyrazine inhibitors of kinases
|
JP5819831B2
(en)
|
2009-08-17 |
2015-11-24 |
インテリカイン, エルエルシー |
Heterocyclic compounds and their use
|
US8669259B2
(en)
|
2009-08-26 |
2014-03-11 |
Merck Sharp & Dohme Corp. |
Heterocyclic amide compounds as protein kinase inhibitors
|
CN101671336B
(en)
|
2009-09-23 |
2013-11-13 |
辽宁利锋科技开发有限公司 |
Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
|
PL2509602T3
(en)
|
2009-12-04 |
2017-08-31 |
Senhwa Biosciences, Inc. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
SG184073A1
(en)
|
2010-03-18 |
2012-10-30 |
Pasteur Institut Korea |
Anti-infective compounds
|
US8518945B2
(en)
|
2010-03-22 |
2013-08-27 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
WO2011121096A1
(en)
|
2010-03-31 |
2011-10-06 |
Dkfz Deutsches Krebsforschungszentrum |
PYRAZOL[1,5-a]PYRIMIDINE DERIVATIVES AS WNT PATHWAY ANTAGONISTS
|
AU2011236510A1
(en)
|
2010-04-08 |
2012-10-11 |
Zoetis Llc |
Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides
|
EP2558866B1
(en)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
CN102947272A
(en)
|
2010-05-12 |
2013-02-27 |
沃泰克斯药物股份有限公司 |
2 -aminopyridine derivatives useful as inhibitors of atr kinase
|
RU2012153675A
(en)
|
2010-05-12 |
2014-06-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
COMPOUNDS USED AS ATR KINASE INHIBITORS
|
EP2568984A1
(en)
|
2010-05-12 |
2013-03-20 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP2569287B1
(en)
|
2010-05-12 |
2014-07-09 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
EP2569286B1
(en)
|
2010-05-12 |
2014-08-20 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
US8962631B2
(en)
|
2010-05-12 |
2015-02-24 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
BR112012029437A2
(en)
|
2010-05-20 |
2017-03-07 |
F Hoffmann - La Roche Ag |
pyrrolo [2,3-b] pyrazine-7-carboxamide derivatives and their use as jak and syk inhibitors
|
MX2012013194A
(en)
|
2010-05-20 |
2013-01-22 |
Hoffmann La Roche |
Pyrrolopyrazine derivatives as syk and jak inhibitors.
|
WO2011163527A1
(en)
|
2010-06-23 |
2011-12-29 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase
|
ES2571334T3
(en)
|
2010-06-24 |
2016-05-24 |
Gilead Sciences Inc |
Pyrazolo [1,5-a] pyrimidines and -triazines as antiviral agents
|
CN102311396B
(en)
|
2010-07-05 |
2015-01-07 |
暨南大学 |
Pyrazine derivative and preparation method as well as application thereof to pharmacy
|
CN110003219A
(en)
|
2010-07-13 |
2019-07-12 |
弗·哈夫曼-拉罗切有限公司 |
Pyrazolo [1,5A] pyrimidine and thieno [3,2B] pyrimidine derivatives as IRAK4 regulator
|
EP2407478A1
(en)
|
2010-07-14 |
2012-01-18 |
GENETADI Biotech, S.L. |
New cyclotetrapeptides with pro-angiogenic properties
|
WO2012022045A1
(en)
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
US8883801B2
(en)
|
2010-08-23 |
2014-11-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
|
US9370567B2
(en)
|
2010-11-16 |
2016-06-21 |
Array Biopharma Inc. |
Combination of checkpoint kinase 1 inhibitors and WEE 1 kinase inhibitors
|
WO2012067822A1
(en)
|
2010-11-16 |
2012-05-24 |
Abbott Laboratories |
Pyrazolo [1, 5 -a] pyrimidin potassium channel modulators
|
JP6154746B2
(en)
|
2010-12-08 |
2017-06-28 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
Substituted pyrazolopyrimidines as glucocerebrosidase activators
|
CA2825098C
(en)
|
2011-01-27 |
2020-03-10 |
Universite De Montreal |
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
|
WO2012138938A1
(en)
|
2011-04-05 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyrazine compounds useful as inhibitors of tra kinase
|
US9029389B2
(en)
|
2011-04-21 |
2015-05-12 |
Institut Pasteur Korea |
Anti-inflammation compounds
|
CA2833698A1
(en)
|
2011-04-21 |
2012-10-26 |
Bayer Intellectual Property Gmbh |
Fluoroalkyl-substituted pyrazolopyridines and use thereof
|
EP2710006A1
(en)
|
2011-05-17 |
2014-03-26 |
Principia Biopharma Inc. |
Azaindole derivatives as tyrosine kinase inhibitors
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
JP2014517079A
(en)
|
2011-06-22 |
2014-07-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Compounds useful as ATR kinase inhibitors
|
WO2012178123A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
JP2014522818A
(en)
|
2011-06-22 |
2014-09-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Compounds useful as ATR kinase inhibitors
|
WO2013010136A2
(en)
|
2011-07-13 |
2013-01-17 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
WO2013052263A2
(en)
|
2011-09-16 |
2013-04-11 |
Microbiotix, Inc. |
Antifungal compounds
|
US8853217B2
(en)
|
2011-09-30 |
2014-10-07 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
EP2751088B1
(en)
|
2011-09-30 |
2016-04-13 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
CN108685922A
(en)
|
2011-09-30 |
2018-10-23 |
沃泰克斯药物股份有限公司 |
With ATR inhibitor for treating cancer of pancreas and non-small cell lung cancer
|
IN2014KN00929A
(en)
|
2011-09-30 |
2015-08-21 |
Vertex Pharma |
|
JP2014528419A
(en)
|
2011-09-30 |
2014-10-27 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Compounds useful as ATR kinase inhibitors
|
KR20140077963A
(en)
|
2011-10-20 |
2014-06-24 |
글락소스미스클라인 엘엘씨 |
Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
|
EP2776420A1
(en)
|
2011-11-09 |
2014-09-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
EP2776421A1
(en)
|
2011-11-09 |
2014-09-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2013071094A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
JP2015502925A
(en)
|
2011-11-09 |
2015-01-29 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of ATR kinase
|
US8841337B2
(en)
|
2011-11-09 |
2014-09-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2013138436A1
(en)
|
2012-03-14 |
2013-09-19 |
Bristol-Myers Squibb Company |
Cyclolic hydrazine derivatives as hiv attachment inhibitors
|
AR090548A1
(en)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS
|
JP6345645B2
(en)
|
2012-04-02 |
2018-06-20 |
サイトキネティックス, インコーポレイテッド |
Methods for improving diaphragm function
|
PL2833973T3
(en)
|
2012-04-05 |
2018-02-28 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase and combination therapies thereof
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CN103373996A
(en)
|
2012-04-20 |
2013-10-30 |
山东亨利医药科技有限责任公司 |
Bicyclic derivatives serving as CRTH2 receptor antagonist
|
KR20240023685A
(en)
|
2012-05-15 |
2024-02-22 |
캔써 리서치 테크놀로지 리미티드 |
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
|
US20130317021A1
(en)
|
2012-05-23 |
2013-11-28 |
Savira Pharmaceuticals Gmbh |
Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral disease
|
JP2015517555A
(en)
|
2012-05-23 |
2015-06-22 |
ザヴィラ ファーマシューティカルズ ゲーエムベーハー |
7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of viral diseases
|
WO2014011911A2
(en)
|
2012-07-11 |
2014-01-16 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
JP2014022472A
(en)
*
|
2012-07-13 |
2014-02-03 |
Sharp Corp |
Light emission device, lighting device, and light emission method
|
WO2014015523A1
(en)
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
RU2015107803A
(en)
|
2012-08-06 |
2016-09-27 |
Савира Фармасьютикалз Гмбх |
DIHYDROXYPYrimidinecarboxylic Acid Derivatives AND THEIR APPLICATION IN TREATMENT, TREATMENT OR PREVENTION OF VIRAL DISEASE
|
EP2895472B1
(en)
|
2012-08-09 |
2016-11-23 |
VIIV Healthcare UK (No.5) Limited |
Tricyclic alkene derivatives as HIV attachment inhibitors
|
EP2895471B1
(en)
|
2012-08-09 |
2016-11-23 |
VIIV Healthcare UK (No.5) Limited |
Piperidine amide derivatives as hiv attachment inhibitors
|
EP2895475B1
(en)
|
2012-08-09 |
2016-11-09 |
VIIV Healthcare UK (No.5) Limited |
Tricyclic amidine derivatives as hiv attachment inhibitors
|
AU2013304133B2
(en)
|
2012-08-17 |
2017-02-23 |
Bayer Cropscience Ag |
Azaindole carboxylic acid amides and azaindole thiocarboxylic acid amides for use as insecticides and acaricides
|
KR20150046056A
(en)
|
2012-08-24 |
2015-04-29 |
에프. 호프만-라 로슈 아게 |
New bicyclicpyridine derivatives
|
WO2014035140A2
(en)
|
2012-08-30 |
2014-03-06 |
Kainos Medicine, Inc. |
Compounds and compositions for modulating histone methyltransferase activity
|
EP2909212B1
(en)
|
2012-09-07 |
2017-02-22 |
Takeda Pharmaceutical Company Limited |
Substituted 1,4-dihydropyrazolo[4,3-b]indoles
|
WO2014042433A2
(en)
|
2012-09-14 |
2014-03-20 |
Kainos Medicine, Inc. |
Compounds and compositions for modulating adenosine a3 receptor activity
|
TW201412740A
(en)
|
2012-09-20 |
2014-04-01 |
Bayer Pharma AG |
Substituted pyrrolopyrimidinylamino-benzothiazolones
|
CN104812389B
(en)
|
2012-09-24 |
2020-07-17 |
润新生物公司 |
Certain chemical entities, compositions, and methods
|
DK2904406T3
(en)
|
2012-10-04 |
2018-06-18 |
Vertex Pharma |
METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
|
WO2014066435A1
(en)
|
2012-10-22 |
2014-05-01 |
City Of Hope |
Etp derivatives
|
AU2013334635B2
(en)
|
2012-10-24 |
2018-12-06 |
Becton, Dickinson And Company |
Hydroxamate substituted azaindoline-cyanine dyes and bioconjugates of the same
|
ES2842876T3
(en)
*
|
2012-12-07 |
2021-07-15 |
Vertex Pharma |
Pyrazolo [1,5-a] pyrimidines useful as ATR kinase inhibitors for the treatment of cancer diseases
|
EP2970289A1
(en)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
JP2016512815A
(en)
|
2013-03-15 |
2016-05-09 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Condensed pyrazolopyrimidine derivatives useful as inhibitors of ATR kinase
|
JP2016512816A
(en)
|
2013-03-15 |
2016-05-09 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
US20150158868A1
(en)
|
2013-12-06 |
2015-06-11 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
DK3077397T3
(en)
|
2013-12-06 |
2019-12-16 |
Vertex Pharma |
2-AMINO-6-FLUOR-N- [5-FLUOR-PYRIDIN-3-YL] PYRAZOLO [1,5-A] PYRIMIDIN-3-CARBOXAMIDE COMPOUND USED AS AN AT-KINASE INHIBITOR, DIFFERENTLY DIFFERENTLY DERIVATIVES THEREOF
|
BR112016028273B1
(en)
|
2014-06-05 |
2022-06-28 |
Vertex Pharmaceuticals Incorporated |
FORMULA I-A COMPOUND, SOLID FORM OF A FORMULA I-1 COMPOUND AND ITS PREPARATION PROCESS
|
DK3157566T3
(en)
|
2014-06-17 |
2019-07-22 |
Vertex Pharma |
METHOD OF TREATING CANCER USING A COMBINATION CHK1 AND ATR INHIBITORS
|